 | • レポートコード：MRC2307A0097 • 出版社/出版日：Transparency Market Research / 2023年4月 • レポート形態：英文、PDF、237ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本報告書は、世界のオルソバイオロジクス市場規模が、2023年の84億ドルから予測期間中、年平均5.5％で成長し、2031年には138億ドルに達すると予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（同種移植片、異種移植片、合成骨移植片、脱灰骨マトリックス、その他）分析、用途別（脊椎固定術、外傷修復、再建手術、骨折、その他）分析、エンドユーザー別（病院、整形外科クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの構成でまとめています。なお、当市場の主要企業には、Alphatec Spine, Inc.、Arthrex、Bioventus LLC、Exactech, Inc.、Global Medical, Inc.、Integra Lifesciences、Medtronic、MTF Biologics、RTI Surgical、Sano Orthopedics、Sanofi、Seikagaku Corporation、Stryker、Zimmer Biometなどがあります。 ・序論 ・仮定＆調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のオルソバイオロジクス市場規模：製品別 - 同種移植片の市場規模 - 異種移植片の市場規模 - 合成骨移植片の市場規模 - 脱灰骨マトリックスの市場規模 - その他製品の市場規模 ・世界のオルソバイオロジクス市場規模：用途別 - 脊椎固定術における市場規模 - 外傷修復における市場規模 - 再建手術における市場規模 - 骨折における市場規模 - その他用途における市場規模 ・世界のオルソバイオロジクス市場規模：エンドユーザー別 - 病院における市場規模 - 整形外科クリニックにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のオルソバイオロジクス市場規模：地域別 - 北米のオルソバイオロジクス市場規模 - ヨーロッパのオルソバイオロジクス市場規模 - アジア太平洋のオルソバイオロジクス市場規模 - 中南米のオルソバイオロジクス市場規模 - 中東・アフリカのオルソバイオロジクス市場規模 ・競争状況 |
Orthobiologics Market – Scope of Report
TMR’s report on the global Orthobiologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Orthobiologics Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Orthobiologics Market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasmonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.
The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the global Orthobiologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Orthobiologics Market profiled in this report.
Key Questions Answered in Global Orthobiologics Market Report
• What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
• What are the opportunities in the global Plasmonic Materials market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Orthobiologics Market – Research Objectives and Research Approach
The comprehensive report on the global Orthobiologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Orthobiologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.
”
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Market Trends
5.2. Merger & Acquisition
5.3. Strategies of Top Five Players Operating in the Market
5.4. Incidence of Orthopedic Disorder, by Key Countries
5.5. Number of Surgical Procedures
5.6. Regulatory and Reimbursement Scenario by Key Countries
5.7. Covid-19 Pandemic Impact on the Industry
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Allografts
6.3.2. Xenografts
6.3.3. Synthetic Bone Grafts
6.3.3.1. Hydroxyapatite
6.3.3.2. β-tricalcium Phosphate (β-TCP)
6.3.3.3. BiPhasic
6.3.3.4. Bioactive Glass
6.3.3.5. Others
6.3.4. Demineralized Bone Matrix (DBM)
6.3.5. Viscosupplementation
6.3.6. Platelet-rich Plasma (PRP)
6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Spinal Fusion
7.3.2. Trauma Repair
7.3.3. Reconstructive Surgeries
7.3.4. Fractures
7.3.5. Osteoarthritis
7.3.6. Maxillofacial & Dental Applications
7.3.7. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Orthopedic Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Allografts
10.2.2. Xenografts
10.2.3. Synthetic Bone Grafts
10.2.3.1. Hydroxyapatite
10.2.3.2. β-tricalcium Phosphate (β-TCP)
10.2.3.3. BiPhasic
10.2.3.4. Bioactive Glass
10.2.3.5. Others
10.2.4. Demineralized Bone Matrix (DBM)
10.2.5. Viscosupplementation
10.2.6. Platelet-rich Plasma (PRP)
10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
10.2.8. Others
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Spinal Fusion
10.3.2. Trauma Repair
10.3.3. Reconstructive Surgeries
10.3.4. Fractures
10.3.5. Osteoarthritis
10.3.6. Maxillofacial & Dental Applications
10.3.7. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Allografts
11.2.2. Xenografts
11.2.3. Synthetic Bone Grafts
11.2.3.1. Hydroxyapatite
11.2.3.2. β-tricalcium Phosphate (β-TCP)
11.2.3.3. BiPhasic
11.2.3.4. Bioactive Glass
11.2.3.5. Others
11.2.4. Demineralized Bone Matrix (DBM)
11.2.5. Viscosupplementation
11.2.6. Platelet-rich Plasma (PRP)
11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
11.2.8. Others
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Spinal Fusion
11.3.2. Trauma Repair
11.3.3. Reconstructive Surgeries
11.3.4. Fractures
11.3.5. Osteoarthritis
11.3.6. Maxillofacial & Dental Applications
11.3.7. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Allografts
12.2.2. Xenografts
12.2.3. Synthetic Bone Grafts
12.2.3.1. Hydroxyapatite
12.2.3.2. β-tricalcium Phosphate (β-TCP)
12.2.3.3. BiPhasic
12.2.3.4. Bioactive Glass
12.2.3.5. Others
12.2.4. Demineralized Bone Matrix (DBM)
12.2.5. Viscosupplementation
12.2.6. Platelet-rich Plasma (PRP)
12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
12.2.8. Others
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Spinal Fusion
12.3.2. Trauma Repair
12.3.3. Reconstructive Surgeries
12.3.4. Fractures
12.3.5. Osteoarthritis
12.3.6. Maxillofacial & Dental Applications
12.3.7. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Allografts
13.2.2. Xenografts
13.2.3. Synthetic Bone Grafts
13.2.3.1. Hydroxyapatite
13.2.3.2. β-tricalcium Phosphate (β-TCP)
13.2.3.3. BiPhasic
13.2.3.4. Bioactive Glass
13.2.3.5. Others
13.2.4. Demineralized Bone Matrix (DBM)
13.2.5. Viscosupplementation
13.2.6. Platelet-rich Plasma (PRP)
13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
13.2.8. Others
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Spinal Fusion
13.3.2. Trauma Repair
13.3.3. Reconstructive Surgeries
13.3.4. Fractures
13.3.5. Osteoarthritis
13.3.6. Maxillofacial & Dental Applications
13.3.7. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Allografts
14.2.2. Xenografts
14.2.3. Synthetic Bone Grafts
14.2.3.1. Hydroxyapatite
14.2.3.2. β-tricalcium Phosphate (β-TCP)
14.2.3.3. BiPhasic
14.2.3.4. Bioactive Glass
14.2.3.5. Others
14.2.4. Demineralized Bone Matrix (DBM)
14.2.5. Viscosupplementation
14.2.6. Platelet-rich Plasma (PRP)
14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
14.2.8. Others
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Spinal Fusion
14.3.2. Trauma Repair
14.3.3. Reconstructive Surgeries
14.3.4. Fractures
14.3.5. Osteoarthritis
14.3.6. Maxillofacial & Dental Applications
14.3.7. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Orthopedic Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share/Ranking Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Alphatec Spine, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Arthrex
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Bioventus LLC
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Exactech, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Global Medical, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Integra Lifesciences
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Medtronic
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. MTF Biologics
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. RTI Surgical
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Sano Orthopedics
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Sanofi
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. Seikagaku Corporation
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. Stryker
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
15.3.14. Zimmer Biomet
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Strategic Overview
Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017‒2031, by Application
Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031